AKSO Biopharmaceutical
PrivateCompany Overview
AKSO Biopharmaceutical is a biopharmaceutical company that develops protein-based therapeutics for the treatment of cancer, autoimmune diseases, and genetic disorders using its proprietary DEEP engineering platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AKSO Biopharmaceutical Comparables
Compare AKSO Biopharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novelogics Biotechnology | 78% | |
| EpimAb Biotherapeutics | 76% | |
| BioAtla | 74% |
AKSO Biopharmaceutical Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 87% MoM.
- Apr 3, 2026
Monthly visitors grew 4127% MoM, reaching 1.7K.
AKSO Biopharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AKSO Biopharmaceutical's valuation, stock price, and market status.
Is AKSO Biopharmaceutical a public or private company?
AKSO Biopharmaceutical is a private company.
What is the current stock price of AKSO Biopharmaceutical?
AKSO Biopharmaceutical is a private company with no public stock price. Caplight tracks AKSO Biopharmaceutical's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is AKSO Biopharmaceutical worth (valuation)?
Valuation information for AKSO Biopharmaceutical is not publicly available.
Can I buy AKSO Biopharmaceutical stock?
AKSO Biopharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AKSO Biopharmaceutical's last funding round?
Funding round information for AKSO Biopharmaceutical is not publicly available.
Who are the main investors in AKSO Biopharmaceutical?
Investor information for AKSO Biopharmaceutical is not publicly disclosed.
Will AKSO Biopharmaceutical IPO soon?
No public IPO plans have been announced for AKSO Biopharmaceutical.
How can I track AKSO Biopharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AKSO Biopharmaceutical's secondary market activity and sign up for updates.